Metis TechBio and Eli Lilly Strike Drug-Delivery Deal Worth Up to $1.1 Billion
Metis TechBio said it entered a collaboration agreement with Eli Lilly to research and develop tissue-specific drug-delivery technologies, worth up to $1.1 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.